Showing results (221-230 of 262) with videos related to
Sort By:
Pageof 27
The Lancet. Gastroenterology & Hepatology|May 10, 2025
Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension studyRemo Panaccione, Séverine Vermeire, Silvio Danese, et al.Digestive Diseases and Sciences|June 24, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision-MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.Journal of Crohn'S & Colitis|March 2, 2016
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's DiseaseFlorian Rieder, Giovanni Latella, Fernando Magro, et al.Research Square|April 27, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trialJurij Hanzel, Sudheer K Vuyyuru, Brian Bressler, et al.The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trialsDavid T Rubin, Iris Dotan, Aaron DuVall, et al.Cellular and Molecular Gastroenterology and Hepatology|November 1, 2016
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic MiceHiroko Nagao-Kitamoto, Andrew B Shreiner, Merritt G Gillilland, et al.The American Journal of Gastroenterology|June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the PouchEdward L Barnes, Laura Raffals, Taha Qazi, et al.Gastrointestinal Endoscopy|December 21, 2014
The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placementNeel S Choksi, Evan L Fogel, Gregory A Cote, et al.Gut|February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trialsJulian Panés, William J Sandborn, Stefan Schreiber, et al.Pageof 27